These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


99 related items for PubMed ID: 3722335

  • 1. Effects of dopamine and metoclopramide in polycystic ovary syndrome.
    Barnes RB, Mileikowsky GN, Cha KY, Spencer CA, Lobo RA.
    J Clin Endocrinol Metab; 1986 Aug; 63(2):506-9. PubMed ID: 3722335
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Prolactin levels in the polycystic ovary syndrome.
    Milewicz A.
    J Reprod Med; 1984 Mar; 29(3):193-6. PubMed ID: 6233421
    [Abstract] [Full Text] [Related]

  • 9. Inhibitory effect of bromocriptine treatment on luteinizing hormone secretion in polycystic ovary syndrome.
    Falaschi P, Rocco A, del Pozo E.
    J Clin Endocrinol Metab; 1986 Feb; 62(2):348-51. PubMed ID: 3510225
    [Abstract] [Full Text] [Related]

  • 10. Secretory dynamics of bioactive and immunoreactive prolactin in polycystic ovary syndrome.
    Anderson RE, Ben-Rafael Z, Flickinger GL, Meloni F, Barnes RB, Rosen GF, Lobo RA.
    Fertil Steril; 1988 Feb; 49(2):239-43. PubMed ID: 3276562
    [Abstract] [Full Text] [Related]

  • 11. [Effects of bromocriptine and dopamine on pituitary hormone secretion in women].
    Masaoka K, Hosoya N, Mori T, Watanabe H, Ohkura T, Kumasaka T.
    Nihon Sanka Fujinka Gakkai Zasshi; 1982 Dec; 34(12):2155-62. PubMed ID: 6818310
    [Abstract] [Full Text] [Related]

  • 12. Prolactin response after gonadotropin-releasing hormone in the polycystic ovary syndrome.
    Shoupe D, Lobo RA.
    Fertil Steril; 1985 Apr; 43(4):549-53. PubMed ID: 3921411
    [Abstract] [Full Text] [Related]

  • 13. Dopamine might not be involved in the pathogenesis of polycystic ovary syndrome.
    Ferriani RA, Silva de Sá MF, Moura MD, Moreira AC, Gomes UA.
    Gynecol Endocrinol; 1989 Dec; 3(4):317-27. PubMed ID: 2516707
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Metoclopramide test in women with PCO syndrome after ovarian wedge resection.
    Vĕtr M, Talas M, Sobek A, Charamza J.
    Acta Univ Palacki Olomuc Fac Med; 1991 Dec; 130():257-64. PubMed ID: 1838876
    [Abstract] [Full Text] [Related]

  • 16. Acute effects of L-dopa and bromocriptine on serum PRL, LH and FSH levels in patients with hyperprolactinemic and normoprolactinemic polycystic ovary syndrome.
    Prelević GM, Würzburger MI, Perić LA.
    J Endocrinol Invest; 1987 Aug; 10(4):389-95. PubMed ID: 3119696
    [Abstract] [Full Text] [Related]

  • 17. Prolactin release in polycystic ovary.
    Falaschi P, del Pozo E, Rocco A, Toscano V, Petrangeli E, Pompei P, Frajese G.
    Obstet Gynecol; 1980 May; 55(5):579-82. PubMed ID: 6768043
    [Abstract] [Full Text] [Related]

  • 18. Prl, TSH, GH and LH responses to metoclopramide and breast-feeding in normal and hyperprolactinaemic women.
    Andersen AN, Tabor A.
    Acta Endocrinol (Copenh); 1982 Jun; 100(2):177-83. PubMed ID: 7202316
    [Abstract] [Full Text] [Related]

  • 19. Hypothalamic dopaminergic tone and prolactin bioactivity in women with polycystic ovary syndrome.
    Hernández I, Parra A, Méndez I, Cabrera V, Cravioto MC, Mercado M, Díaz-Sánchez V, Larrea F.
    Arch Med Res; 2000 Jun; 31(2):216-22. PubMed ID: 10880731
    [Abstract] [Full Text] [Related]

  • 20. Naloxone does not interfere with the dopamine-induced decrease in gonadotropin secretion in women with polycystic ovarian disease.
    Paradisi R, Margrini O, Venturoli S, Fabbri R, Porcu E, Stanzani L, Flamigni C.
    Horm Metab Res; 1985 Jan; 17(1):29-31. PubMed ID: 3917966
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.